Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP521 | DOI: 10.1530/endoabs.99.EP521

Hedi Chaker Sfax, Endocrinology Department, Tunisia


Introduction: Moringa is a common tropical tree in Africa that has become a subject of interest for scientists due to its interesting composition and nutritional qualities. The objective of this study was to evaluate the effects of Moringa oleifera powder on metabolic parameters in diabetic patients in the short term.

Method: We conducted a randomized controlled study with ten type 2 diabetic patients treated with oral antidiabetic medications. Each patient received 5 g of Moringa powder per day for 15 days, followed by 8 g per day for the next 15 days. Glycemic and lipid profiles were assessed before the protocol, on day 15, and on day 30.

Results: There was a female predominance (80%) in the study. Hypertension was found in 80% of patients, and obesity was present in 20% of patients. Before the protocol, the average fasting blood glucose was 8.61±3.51 mmol/l, and the average HbA1C was 7.93±3.67%. After 30 days of Moringa powder consumption, a decrease of 18.73% in fasting blood glucose was observed. Regarding HbA1C, no significant change was noted after 30 days. Analysis of the lipid profile showed a decrease of 13.05% in total cholesterol and a decrease of 19.62% in triglyceride levels after 30 days of Moringa powder consumption.

Conclusion: While further research is needed to confirm these observations, these results suggest that Moringa oleifera could be considered as a potential dietary supplement to improve metabolic parameters in individuals with type 2 diabetes.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.